Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析

◆英語タイトル:Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15082
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection prophylaxis and imbalanced immune responses, among others. It has developed M-Gard, an immunomodulator that enhances your body’s vital defence mechanisms against pathogens such as bacteria, virus, and fungus. Biotec Pharmacon carries out cellular or molecular level research on its proprietary beta-1,3 and 1,6-glucan products, a non-toxic modulator that improves immune resistance. The company operates through its subsidiaries in Tromso. Biotec Pharmacon is headquartered in Tromso, Norway.

Biotec Pharmacon ASA Key Recent Developments

Feb 07,2019: Biotec Pharmacon’s subsidiary, ArcticZymes launches its first ligase enzyme
Jan 30,2019: Biotec Pharmacon Q4 2018 Results
Oct 18,2018: Biotec Pharmacon: Results for Q3 2018
Sep 30,2018: ArcticZymes secures first supply agreement for utility of Salt Active Nuclease in Gene Therapy

This comprehensive SWOT profile of Biotec Pharmacon ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biotec Pharmacon ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Biotec Pharmacon ASA – Key Information
Biotec Pharmacon ASA – Overview
Biotec Pharmacon ASA – Key Employees
Biotec Pharmacon ASA – Key Employee Biographies
Biotec Pharmacon ASA – Key Operational Heads
Biotec Pharmacon ASA – Major Products and Services
Biotec Pharmacon ASA – History
Biotec Pharmacon ASA – Company Statement
Biotec Pharmacon ASA – Locations And Subsidiaries
Biotec Pharmacon ASA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biotec Pharmacon ASA – Business Description
Biotec Pharmacon ASA – Corporate Strategy
Biotec Pharmacon ASA – SWOT Analysis
SWOT Analysis – Overview
Biotec Pharmacon ASA – Strengths
Biotec Pharmacon ASA – Weaknesses
Biotec Pharmacon ASA – Opportunities
Biotec Pharmacon ASA – Threats
Biotec Pharmacon ASA – Key Competitors

Section 3 – Company Financial Performance Charts

Biotec Pharmacon ASA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biotec Pharmacon ASA, Key Information
Biotec Pharmacon ASA, Key Ratios
Biotec Pharmacon ASA, Share Data
Biotec Pharmacon ASA, Major Products and Services
Biotec Pharmacon ASA, History
Biotec Pharmacon ASA, Key Employees
Biotec Pharmacon ASA, Key Employee Biographies
Biotec Pharmacon ASA, Key Operational Heads
Biotec Pharmacon ASA, Other Locations
Biotec Pharmacon ASA, Subsidiaries
Biotec Pharmacon ASA, Key Manufacturing facilities
Biotec Pharmacon ASA, Key Competitors
Biotec Pharmacon ASA, SWOT Analysis
Biotec Pharmacon ASA, Ratios based on current share price
Biotec Pharmacon ASA, Annual Ratios
Biotec Pharmacon ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biotec Pharmacon ASA, Performance Chart
Biotec Pharmacon ASA, Ratio Charts

★海外企業調査レポート[Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dexia Group:戦略・SWOT・企業財務分析
    Dexia Group - Strategy, SWOT and Corporate Finance Report Summary Dexia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Tenneco Inc.:企業の戦略・SWOT・財務分析
    Tenneco Inc. - Strategy, SWOT and Corporate Finance Report Summary Tenneco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Valecha Engineering Ltd
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ceres Power Holdings Plc (CWR):電力:M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報
    Summary Uscom Ltd. (Uscom) is a medical device company that operates in non-invasive hemodynamic market. It focuses on the development, design, manufacture and marketing of non-invasive cardiac monitoring devices. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac o …
  • Dalton Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary Dalton Pharma Services (Dalton) is a contract manufacturing company that offers discovery, development and contract manufacturing services. The company’s product categories include building blocks, coelenterazines, drugs and metabolites, glitazones, gmp APIs, excipients and reagents, heteroc …
  • Tyser & Co Limited:企業の戦略的SWOT分析
    Tyser & Co Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Dubai Electricity and Water Authority:企業の戦略的SWOT分析
    Dubai Electricity and Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Rush Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DormaKaba Holding AG:企業の戦略・SWOT・財務情報
    DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report Summary DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Agilvax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • United Overseas Bank Ltd:戦略・SWOT・企業財務分析
    United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Medovex Corp (MDVX):医療機器:M&Aディール及び事業提携情報
    Summary Medovex Corp (Medovex) is a medical device company. The company operates in designing and marketing medical devices for commercial use. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications including pain relief from chronic back pain caused …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆